AAAAAA

   
Results: 1-9 |
Results: 9
CATCH-UP PRIMARY VACCINATION WITH ACELLULAR PERTUSSIS VACCINES IN 3-4-YEAR-OLD CHILDREN - REACTOGENICITY AND SEROLOGICAL RESPONSE
Authors: WARNGARD O NILSSON L FAHRAEUS C GUSTAFSSON L HALLANDER HO OLIN P STORSAETER J
Citation: O. Warngard et al., CATCH-UP PRIMARY VACCINATION WITH ACELLULAR PERTUSSIS VACCINES IN 3-4-YEAR-OLD CHILDREN - REACTOGENICITY AND SEROLOGICAL RESPONSE, Vaccine, 16(5), 1998, pp. 480-484
LEVELS OF ANTI-PERTUSSIS ANTIBODIES RELATED TO PROTECTION AFTER HOUSEHOLD EXPOSURE TO BORDETELLA-PERTUSSIS
Authors: STORSAETER J HALLANDER HO GUSTAFSSON L OLIN P
Citation: J. Storsaeter et al., LEVELS OF ANTI-PERTUSSIS ANTIBODIES RELATED TO PROTECTION AFTER HOUSEHOLD EXPOSURE TO BORDETELLA-PERTUSSIS, Vaccine, 16(20), 1998, pp. 1907-1916
RANDOMIZED CONTROLLED TRIAL OF 2-COMPONENT, 3-COMPONENT, AND 5-COMPONENT ACELLULAR PERTUSSIS VACCINES COMPARED WITH WHOLE-CELL PERTUSSIS-VACCINE
Authors: OLIN P RASMUSSEN F GUSTAFSSON L HALLANDER HO HEIJBEL H
Citation: P. Olin et al., RANDOMIZED CONTROLLED TRIAL OF 2-COMPONENT, 3-COMPONENT, AND 5-COMPONENT ACELLULAR PERTUSSIS VACCINES COMPARED WITH WHOLE-CELL PERTUSSIS-VACCINE, Lancet, 350(9091), 1997, pp. 1569-1577
VALIDATION OF NESTED BORDETELLA PCR IN PERTUSSIS-VACCINE TRIAL
Authors: REIZENSTEIN E LINDBERG L MOLLBY R HALLANDER HO
Citation: E. Reizenstein et al., VALIDATION OF NESTED BORDETELLA PCR IN PERTUSSIS-VACCINE TRIAL, Journal of clinical microbiology, 34(4), 1996, pp. 810-815
A CONTROLLED TRIAL OF A 2-COMPONENT ACELLULAR, A 5-COMPONENT ACELLULAR, AND A WHOLE-CELL PERTUSSIS-VACCINE
Authors: GUSTAFSSON L HALLANDER HO OLIN P REIZENSTEIN E STORSAETER J
Citation: L. Gustafsson et al., A CONTROLLED TRIAL OF A 2-COMPONENT ACELLULAR, A 5-COMPONENT ACELLULAR, AND A WHOLE-CELL PERTUSSIS-VACCINE, The New England journal of medicine, 334(6), 1996, pp. 349-355
ATYPICAL MYCOBACTERIA IN EXTRAPULMONARY DISEASE AMONG CHILDREN - INCIDENCE IN SWEDEN FROM 1969 TO 1990, RELATED TO CHANGING BCG-VACCINATIONCOVERAGE
Authors: ROMANUS V HALLANDER HO WAHLEN P OLINDERNIELSEN AM MAGNUSSON PHW JUHLIN I
Citation: V. Romanus et al., ATYPICAL MYCOBACTERIA IN EXTRAPULMONARY DISEASE AMONG CHILDREN - INCIDENCE IN SWEDEN FROM 1969 TO 1990, RELATED TO CHANGING BCG-VACCINATIONCOVERAGE, Tubercle and lung disease, 76(4), 1995, pp. 300-310
COMPARISON OF 5 CALCULATION MODES FOR ANTIBODY ELISA PROCEDURES USINGPERTUSSIS SEROLOGY AS A MODEL
Authors: REIZENSTEIN E HALLANDER HO BLACKWELDER WC KUHN I LJUNGMAN M MOLLBY R
Citation: E. Reizenstein et al., COMPARISON OF 5 CALCULATION MODES FOR ANTIBODY ELISA PROCEDURES USINGPERTUSSIS SEROLOGY AS A MODEL, Journal of immunological methods, 183(2), 1995, pp. 279-290
EXPERIENCE FROM AN EXTERNAL QUALITY ASSESSMENT PROGRAM FOR CLINICAL BACTERIOLOGY IN SWEDEN, 1987-1992
Authors: HALLANDER HO DIMANDER M
Citation: Ho. Hallander et M. Dimander, EXPERIENCE FROM AN EXTERNAL QUALITY ASSESSMENT PROGRAM FOR CLINICAL BACTERIOLOGY IN SWEDEN, 1987-1992, Medical microbiology letters, 3(3), 1994, pp. 142-151
DIAGNOSTIC EVALUATION OF POLYMERASE CHAIN-REACTION DISCRIMINATIVE FORBORDETELLA-PERTUSSIS, B-PARAPERTUSSIS AND B-BRONCHISEPTICA
Authors: REIZENSTEIN E JOHANSSON B MARDIN L ABENS J MOLLBY R HALLANDER HO
Citation: E. Reizenstein et al., DIAGNOSTIC EVALUATION OF POLYMERASE CHAIN-REACTION DISCRIMINATIVE FORBORDETELLA-PERTUSSIS, B-PARAPERTUSSIS AND B-BRONCHISEPTICA, Diagnostic microbiology and infectious disease, 17(3), 1993, pp. 185-191
Risultati: 1-9 |